We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current INSP market cap is 5.42B. The company's latest EPS is USD 1.8035 and P/E is 101.21.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 192.51M | 164.01M | 195.89M | 203.19M | 239.72M |
| Operating Income | 9.3M | -15.22M | 5.1M | 14.32M | 31.88M |
| Net Income | 14.76M | -10.01M | 9.79M | 18.5M | 35.22M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 115.38M | 233.39M | 407.86M | 624.8M | 802.8M |
| Operating Income | -56.21M | -39.85M | -47.59M | -40.27M | 36.08M |
| Net Income | -57.2M | -42.04M | -44.88M | -21.15M | 53.51M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 676.81M | 685.84M | 728.39M | 796.19M | 808.38M |
| Total Liabilities | 104.3M | 96.82M | 90.32M | 99.63M | 118.69M |
| Total Equity | 572.51M | 589.02M | 638.07M | 696.56M | 689.7M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 281.19M | 295.08M | 564.88M | 676.81M | 808.38M |
| Total Liabilities | 51.44M | 66.04M | 68.87M | 104.3M | 118.69M |
| Total Equity | 229.75M | 229.05M | 496.01M | 572.51M | 689.7M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 24.65M | 8.86M | 8.78M | 61.07M | 130.25M |
| Investing | -294.82M | -19.54M | -13.92M | -116.88M | -113.12M |
| Financing | 13.95M | 768k | 7.86M | 17.75M | -52.39M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -53.05M | -20.12M | 11.57M | 24.65M | 130.25M |
| Investing | 86.63M | 29.14M | -19.6M | -294.82M | -113.12M |
| Financing | 134.07M | 14.95M | 235.08M | 13.95M | -52.39M |
| Market Cap | 5.42B |
| Price to Earnings Ratio | 101.21 |
| Price to Sales Ratio | 6.75 |
| Price to Cash Ratio | 36.07 |
| Price to Book Ratio | 7.85 |
| Dividend Yield | - |
| Shares Outstanding | 29.67M |
| Average Volume (1 week) | 441.43k |
| Average Volume (1 Month) | 590.66k |
| 52 Week Change | -7.81% |
| 52 Week High | 257.40 |
| 52 Week Low | 123.00 |
| Spread (Intraday) | 0.79 (0.43%) |
| Company Name | Inspire Medical Systems Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.inspiresleep.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
